U-Blot® Research Grade Anti-Human DLK1 (CBA-1205)Cat. No. WA1864Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human DLK1 (CBA-1205)Cat. No. WA1864
U-Blot® Research Grade Anti-Human DLK1 (ADCT-701)Cat. No. WA1863
U-Blot® Research Grade Anti-Human DKK1 (PF-04840082)Cat. No. WA1862
U-Blot® Research Grade Anti-Human DCBLD2/CLCP1 Antibody (FA19-1)Cat. No. WA1861
U-Blot® Research Grade Anti-Human DAG1/Dystroglycan (DAG-6F4)Cat. No. WA1860
U-Blot® Research Grade Anti-Human CXCL13/BCA-1/BLC (VX5/5261)Cat. No. WA1859
U-Blot® Research Grade Anti-Human CXCL13/BCA-1/BLC (TJX7)Cat. No. WA1858
U-Blot® Research Grade Anti-Human CXCL12/SDF-1 Antibody (Genentech anti-CXCL12)Cat. No. WA1857
U-Blot® Research Grade Anti-Human CXCL10/IP-10 (NI-0801)Cat. No. WA1856
U-Blot® Research Grade Anti-Human CX43/GJA1 (ALMB-0168)Cat. No. WA1855
U-Blot® Research Grade Anti-Human CX3CR1 Antibody (BI 655089)Cat. No. WA1854
U-Blot® Research Grade Anti-Human CX3CR1 & Albumin Antibody (BI 655088)Cat. No. WA1853